79355199

Information

  • Trademark
  • 79355199
  • Serial Number
    79355199
  • Registration Number
    7129133
  • Filing Date
    September 28, 2022
    2 years ago
  • Registration Date
    August 08, 2023
    a year ago
  • Transaction Date
    November 14, 2023
    a year ago
  • Status Date
    August 08, 2023
    a year ago
  • Published for Opposition Date
    May 23, 2023
    a year ago
  • Location Date
    August 08, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    EISNACH, MICHAEL PATRI
  • Attorney Docket Number
    0332003
    Attorney Name
    M. Scott Alprin
    Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
2000
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
  • DM0000: The mark consists of two wavy lines resembling double-stranded DNA in navy together with three comet-like figures in orange. The white in the mark is background only and is not claimed as a feature of the mark.
  • GS0051: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
  • CC0000: The color(s) navy and orange is/are claimed as a feature of the mark.
  • GS0011: Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
  • GS0451: Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights
  • GS0421: Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances
Case File Event Statements
  • 11/14/2023 - a year ago
    25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 11/14/2023 - a year ago
    24 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 11/8/2023 - a year ago
    23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 8/8/2023 - a year ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/8/2023 - a year ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/24/2023 - a year ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 5/23/2023 - a year ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/23/2023 - a year ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/3/2023 - a year ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/3/2023 - a year ago
    16 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 5/3/2023 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/19/2023 - a year ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/18/2023 - a year ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/17/2023 - a year ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/17/2023 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/7/2023 - a year ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/15/2023 - a year ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/15/2023 - a year ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/20/2022 - 2 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/19/2022 - 2 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/9/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/29/2022 - 2 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/23/2022 - 2 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/22/2022 - 2 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 11/17/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR